Literature DB >> 35101994

Cisplatin-Induced Kidney Injury: Delivering the Goods.

Joshua N Curry1, James A McCormick2.   

Abstract

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; cisplatin nephrotoxicity; renalase

Mesh：

Substances：

Year:  2022        PMID： 35101994      PMCID： PMC8819980          DOI： 10.1681/ASN.2021121591

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  Mesoscale nanoparticles selectively target the renal proximal tubule epithelium.

Authors:  Ryan M Williams; Janki Shah; Brandon D Ng; Denise R Minton; Lorraine J Gudas; Christopher Y Park; Daniel A Heller
Journal:  Nano Lett       Date:  2015-03-26       Impact factor: 11.189

2.  Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.

Authors:  Jianchao Xu; Guoyong Li; Peili Wang; Heino Velazquez; Xiaoqiang Yao; Yanyan Li; Yanling Wu; Aldo Peixoto; Susan Crowley; Gary V Desir
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

3.  Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.

Authors:  Xiaojia Guo; Leyuan Xu; Heino Velazquez; Tian-Min Chen; Ryan M Williams; Daniel A Heller; Barbara Burtness; Robert Safirstein; Gary V Desir
Journal:  J Am Soc Nephrol       Date:  2021-12-17       Impact factor: 10.121

Review 4.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

5.  Renalase prevents AKI independent of amine oxidase activity.

Authors:  Ling Wang; Heino Velazquez; Gilbert Moeckel; John Chang; Ahrom Ham; H Thomas Lee; Robert Safirstein; Gary V Desir
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

6.  Renalase protects against ischemic AKI.

Authors:  H Thomas Lee; Joo Yun Kim; Mihwa Kim; Peili Wang; Lieqi Tang; Sara Baroni; Vivette D D'Agati; Gary V Desir
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

7.  Long-Term Renal Outcomes after Cisplatin Treatment.

Authors:  Sheron Latcha; Edgar A Jaimes; Sujata Patil; Ilya G Glezerman; Swati Mehta; Carlos D Flombaum
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

8.  Identification of a receptor for extracellular renalase.

Authors:  Ling Wang; Heino Velazquez; John Chang; Robert Safirstein; Gary V Desir
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

9.  Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection.

Authors:  Yasuhiro Kidera; Hisato Kawakami; Tsutomu Sakiyama; Kunio Okamoto; Kaoru Tanaka; Masayuki Takeda; Hiroyasu Kaneda; Shin-ichi Nishina; Junji Tsurutani; Kimiko Fujiwara; Morihiro Nomura; Yuzuru Yamazoe; Yasutaka Chiba; Shozo Nishida; Takao Tamura; Kazuhiko Nakagawa
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

10.  Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer.

Authors:  Xiaojia Guo; Lindsay Hollander; Douglas MacPherson; Ling Wang; Heino Velazquez; John Chang; Robert Safirstein; Charles Cha; Fred Gorelick; Gary V Desir
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379
  10 in total
  1 in total

1.  Bibliometric and visual analysis of nephrotoxicity research worldwide.

Authors:  Tianmu He; Jingwen Ao; Cancan Duan; Rong Yan; Xiaomei Li; Liu Liu; Jianyong Zhang; Xiaofei Li
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.